Molecular and Thermodynamic Studies on DNA Triplex Formed in the Promoter Region of HMGB1 Gene as a Selective Target for Anticancer Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|17|12|1698-1709

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.17, Iss.12, 2018-01, pp. : 1698-1709

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs

By Jin Wei  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 39-48

Springer Publishing Company

Access to resources Recommend Favorite

Translational studies for target-based drugs

By Nishio Kazuto   Arao Tokuzo   Shimoyama Tatsu   Fujiwara Yasuhiro   Tamura Tomohide   Saijo Nagahiro  

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 90-93

Springer Publishing Company

Access to resources Recommend Favorite

Tyrosyl-DNA Phosphodiesterase as a Target for Anticancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 4, 2008-05 ,pp. : 381-389

Bentham Science Publishers

Access to resources Recommend Favorite

DNA Helicases as Targets for Anti-Cancer Drugs

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 3, 2005-05 ,pp. : 183-199

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs

By Sun Yanlin  

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 591-599

Springer Publishing Company

Access to resources Recommend Favorite